Back to Ovarian Cancer
NCT00002568
NCT00002568
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with primary ovarian cancer that has been confirmed by a tissue sample (biopsy)
- Your cancer is Stage III, meaning more than 1 cm of cancer remained in the abdomen after surgery to remove as much of the tumor as possible
- Your surgery involved open abdominal surgery (keyhole/laparoscopic surgery alone is not enough to qualify)
- Your cancer is one of these specific types: serous adenocarcinoma, transitional cell carcinoma, mucinous adenocarcinoma, undifferentiated carcinoma, clear cell adenocarcinoma, mixed epithelial carcinoma, adenocarcinoma, endometrioid tumor, adenocarcinoma NOS, or malignant Brenner's tumor
- You are well enough to carry out light activity or normal daily tasks (your doctor will assess this)
- Your blood cell counts are at healthy enough levels (your doctor will check your white blood cells, platelets, and other counts)
- Your liver is functioning within an acceptable range (confirmed by blood tests)
- Your kidneys are functioning within an acceptable range (confirmed by a blood test)
- Your staging surgery took place no more than 6 weeks ago
- You are any age
Who may not be able to join:
- Your ovarian cancer has not been confirmed by tissue testing, or it cannot be clearly confirmed as starting in the ovary
- Your cancer is classified as "borderline," grade 0, or described as "probably malignant" rather than confirmed cancer
- You have a history of heart failure or have had a heart attack within the last 6 months
- You currently have unstable chest pain (unstable angina)
- You have a serious active infection or blood poisoning (septicemia)
- You have active hepatitis (liver inflammation)
- You have severe bleeding in your digestive system
- You have had another cancer within the last 5 years (except for certain common skin cancers)
- You are currently pregnant or breastfeeding
- You are able to become pregnant but are not using effective contraception
- You have had chemotherapy before
- You have had radiation therapy before
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 3
Sponsor
Gynecologic Oncology Group
Registry
clinicaltrials_gov
Start date
1 June 1994
Est. completion
1 December 2004
Where this trial is recruiting
🇺🇸 United States
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.